Microscopic and ultrastructural features in Wolcott-Rallison syndrome, a permanent neonatal diabetes mellitus: About two autopsy cases

Pediatric Diabetes

Volumn 16, Issue 7, 2015, Pages 510-520

  Collardeau Frachon, Sophie ^a   Vasiljevic, Alexandre ^a   Jouvet, Anne ^a   Bouvier, Raymonde ^a   Senée, Valérie ^b   Nicolino, Marc ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b INSERM   (France)

Author keywords

Diabetes mellitus permanent neonatal; Endoplasmic reticulum; Liver steatosis; Pathology; Wolcott Rallison syndrome

Indexed keywords

INITIATION FACTOR 2ALPHA; MEMBRANE PROTEIN; EIF2AK3 PROTEIN, HUMAN; PROTEIN KINASE R;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE DYSPLASIA; CASE REPORT; CHILD; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; EXOCRINE CELL; GENE MUTATION; GENETIC CODE; GROWTH RETARDATION; HEART MUSCLE; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY; KIDNEY TUBULE CELL; LIVER; LIVER CELL; LIVER DYSFUNCTION; MALE; NEONATAL DIABETES MELLITUS; PANCREAS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FOLDING; STEATOSIS; ULTRASTRUCTURE; WOLCOTT RALLISON SYNDROME; AUTOPSY; CARDIAC MUSCLE; CONGENITAL MALFORMATION; CONSANGUINITY; DELAYED DIAGNOSIS; DIABETES MELLITUS, TYPE 1; EPIPHYSIS; FAMILY HEALTH; GENETICS; HEART; LIVER FAILURE, ACUTE; METABOLISM; MUTATION; OSTEOCHONDRODYSPLASIAS; PATHOLOGY; PATHOPHYSIOLOGY;

AUTOPSY; CONSANGUINITY; DELAYED DIAGNOSIS; DIABETES MELLITUS, TYPE 1; EIF-2 KINASE; ENDOPLASMIC RETICULUM; EPIPHYSES; FAMILY HEALTH; HEART; HUMANS; INFANT; KIDNEY; LIVER; LIVER FAILURE, ACUTE; MALE; MUTATION; MYOCARDIUM; OSTEOCHONDRODYSPLASIAS; PANCREAS;

EID: 84942988433     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12201     Document Type: Article

References (30)

1. Senée V, Vattem KM, Delépine M et al. Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004: 53: 1876-1883.
2. Rubio-Cabezas O, Patch AM, Minton JA et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 2009: 94: 4162-4170.
3. Ozbek MN, Senée V, Aydemir S et al. Wolcott-Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature. Pediatr Diabetes 2010: 11: 279-285.
4. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis 2010: 4: 29.
5. Habeb AM. Frequency and spectrum of Wolcott-Rallison syndrome in Saudi Arabia: a systematic review. Libyan J Med 2013: 10: 21137.
6. Delépine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000: 25: 406-409.
7. Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 2002: 51 (Suppl. 3): S455-S461.
8. Shi Y, Taylor SI, Tan SL, Sonenberg N. When translation meets metabolism: multiple links to diabetes. Endocr Rev 2003: 24: 91-101.
9. Thomas SE, Dalton LE, Daly ML, Malzer E, Marciniak SJ. Diabetes as a disease of endoplasmic reticulum stress. Diabetes Metab Res Rev 2010: 26: 611-621.
10. Brickwood S, Bonthron DT, Al-Gazali LI et al. Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet 2003: 40: 685-689.
11. Engelmann G, Meyburg J, Shahbek N et al. Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome. J Inherit Metab Dis 2008: 31: 540-546.
12. Shi Y, Vattem KM, Sood R et al. Identification and characterization of pancreatic eukaryotic initiation factor 2 -subunit kinase, PEK, involved in translational control. Mol Cell Biol 1998: 18: 7499-7509.
13. Scheuner D, Song B, McEwen E et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 2001: 7: 1165-1176.
14. Harding HP, Zeng H, Zhang Y et al. Diabetes mellitus and excocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in survival of secretory cells. Mol Cell 2001: 7: 1153-1163.
15. Zhang P, McGrath B, Li S et al. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 2002: 22: 3864-3874.
16. Li Y, Iida K, O'Neil J et al. PERK eIF2alpha kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth factor-I derived from the liver. Endocrinology 2003: 144: 3505-3513.
17. Jiang HY, Wek SA, McGrath BC et al. Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol 2003: 23: 5651-5663.
18. Iida K, Li Y, McGrath BC, Frank A, Cavener DR. PERK eIF2 alpha kinase is required to regulate the viability of the exocrine pancreas in mice. BMC Cell Biol 2007: 8: 38.
19. Zhang W, Feng D, Li Y, Iida K, McGrath B, Cavener DR. PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis. Cell Metab 2006: 4: 491-497.
20. Wei J, Sheng X, Feng D, McGrath B, Cavener DR. PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol 2008: 217: 693-707.
21. Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. BMC Cell Biol 2009: 4: 61.
22. Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes 2010: 59: 1937-1947.
23. Wolcott CD, Rallison ML. Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972: 80: 292-297.
24. Castelnau P, Le Merrer M, Diatloff-Zito C, Marquis E, Tête MJ, Robert JJ. Wolcott-Rallison syndrome: a case with endocrine and exocrine pancreatic deficiency and pancreatic hypotrophy. Eur J Pediatr 2000: 159: 631-633.
25. Thornton CM, Carson DJ, Stewart FJ. Autopsy findings in the Wolcott-Rallison syndrome. Pediatr Pathol Lab Med 1997: 17: 487-496.
26. Søvik O, Njølstad PR, Jellum E, Molven A. Wolcott-Rallison syndrome with 3-hydroxydicarboxylic aciduria and lethal outcome. J Inherit Metab Dis 2008: 31 (Suppl. 2): S293-S297.
27. Iyer S, Korada M, Rainbow L et al. Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr 2004: 93: 1195-1201.
28. Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology 2011: 53: 1752-1763.
29. Kammoun HL, Hainault I, Ferré P, Foufelle F. Nutritional related liver disease: targeting the endoplasmic reticulum stress. Curr Opin Clin Nutr Metab Care 2009: 12: 575-582.
30. de Wit MC, de Coo IF, Julier C et al. Microcephaly and simplified gyral pattern of the brain associated with early onset insulin-dependent diabetes mellitus. Neurogenetics 2006: 7: 259-263.